Zurich Cantonal Bank’s AMAG Pharmaceuticals AMAG Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-2,423
| Closed | -$23K | – | 2655 |
|
|
2020
Q3 | $23K | Hold |
2,423
| – | – | ﹤0.01% | 2474 |
|
|
2020
Q2 | $19K | Hold |
2,423
| – | – | ﹤0.01% | 2470 |
|
|
2020
Q1 | $15K | Hold |
2,423
| – | – | ﹤0.01% | 2423 |
|
|
2019
Q4 | $29K | Hold |
2,423
| – | – | ﹤0.01% | 2402 |
|
|
2019
Q3 | $28K | Hold |
2,423
| – | – | ﹤0.01% | 2340 |
|
|
2019
Q2 | $24K | Hold |
2,423
| – | – | ﹤0.01% | 2424 |
|
|
2019
Q1 | $31K | Hold |
2,423
| – | – | ﹤0.01% | 2262 |
|
|
2018
Q4 | $37K | Hold |
2,423
| – | – | ﹤0.01% | 2206 |
|
|
2018
Q3 | $48K | Hold |
2,423
| – | – | ﹤0.01% | 2181 |
|
|
2018
Q2 | $47K | Buy |
2,423
+1,374
| +131% | +$30.4K | ﹤0.01% | 2176 |
|
|
2018
Q1 | $21K | Hold |
1,049
| – | – | ﹤0.01% | 2406 |
|
|
2017
Q4 | $14K | Hold |
1,049
| – | – | ﹤0.01% | 2466 |
|
|
2017
Q3 | $19K | Hold |
1,049
| – | – | ﹤0.01% | 2282 |
|
|
2017
Q2 | $19K | Hold |
1,049
| – | – | ﹤0.01% | 2279 |
|
|
2017
Q1 | $24K | Hold |
1,049
| – | – | ﹤0.01% | 2236 |
|
|
2016
Q4 | $37K | Hold |
1,049
| – | – | ﹤0.01% | 1905 |
|
|
2016
Q3 | $26K | Buy |
1,049
+227
| +28% | +$5.67K | ﹤0.01% | 2132 |
|
|
2016
Q2 | $20K | Hold |
822
| – | – | ﹤0.01% | 2120 |
|
|
2016
Q1 | $19K | Hold |
822
| – | – | ﹤0.01% | 2106 |
|
|
2015
Q4 | $25K | Buy |
822
+368
| +81% | +$11.9K | ﹤0.01% | 1900 |
|
|
2015
Q3 | $18K | Buy |
454
+318
| +234% | +$19.7K | ﹤0.01% | 1549 |
|
|
2015
Q2 | $9K | Hold |
136
| – | – | ﹤0.01% | 1481 |
|
|
2015
Q1 | $7K | Buy |
+136
| New | +$6.48K | ﹤0.01% | 1656 |
|
Zurich Cantonal Bank's AMAG Position: Q4 2020 in Review
Zurich Cantonal Bank sold out of AMAG Pharmaceuticals (AMAG) in Q4 2020, closing a stake of 2,423 shares — an estimated $23K sold.
Zurich Cantonal Bank first reported a position in AMAG in Q1 2015 and held it in 23 quarters. The position peaked at $48K in Q3 2018. 1 fund tracked by Wall St. Rank holds AMAG as of Q4 2020.
- Zurich Cantonal Bank reported no remaining AMAG Pharmaceuticals position as of Q4 2020 after selling out during the quarter.
- Zurich Cantonal Bank sold 2,423 AMAG Pharmaceuticals shares in Q4 2020, an estimated $23K.
- Zurich Cantonal Bank first reported a position in AMAG Pharmaceuticals in Q1 2015 and held it in 23 quarters.
- Zurich Cantonal Bank's AMAG Pharmaceuticals position peaked at $48K in Q3 2018.
- 1 fund tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q4 2020.
Based on Zurich Cantonal Bank's 13F filing for Q4 2020, filed 28 Jan 2021.